Clinical Trial

PRA-216 COPD Safety and Biomarker Study

Name: PRA-216 COPD Safety and Biomarker Study — clinical trial record (NCT07730281)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study will evaluate the safety, tolerability, pharmacokinetics and immunogenicity of PRA-216 compared to placebo in patients with chronic obstructive pulmonary disease (COPD).

Trial Details

NCT Number	NCT07730281
Lead Sponsor	Prana Therapies Inc
Conditions	Chronic Obstructive Pulmonary Disease (COPD)
Enrollment	40 participants
Start Date	2026-08-01
Primary Completion	2027-06-01 (estimated)
Study Completion	2027-09-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-28